Related Experiment Video
Updated: Apr 23, 2026

A Reproducible Intensive Care Unit-Oriented Endotoxin Model in Rats
Published on: February 20, 2021
Elevated β-lactam concentrations associated with neurological deterioration in ICU septic patients
1Department of Intensive Care, Erasme Hospital, Université Libre de Bruxelles (ULB), Brussels, Belgium - ftaccone@ulb.ac.be.
Background:
Although β-lactams are considered to have a safe therapeutic profile, neurotoxicity has been reported. The aim of this study was to assess the association between β-lactam concentrations and neurological alterations in septic ICU patients.
Methods:
Retrospective study on all ICU patients who were treated with meropenem (MEM), piperacillin-tazobactam (TZP) or ceftazidime/cefepime (CEF) and in whom at least one β-lactam trough concentration (C min) was determined. Drug levels were measured using high-performance liquid chromatography; C min was normalized to the clinical breakpoint of Pseudomonas aeruginosa (as determined by EUCAST) for each drug (C min/MIC). Changes in neurological status were evaluated using changes in the neurological sequential organ failure assessment score (ΔnSOFA) using the formula: ΔnSOFA = nSOFA(day of TDM) - nSOFA(ICU admission). Worsening neurological status (NWS) was defined as a ΔnSOFA ≥ 1 for an nSOFA on admission of 0-2.
Results:
We collected 262 C min in 199 patients (130 MEM, 85 TZP, 47 CEF). Median APACHE II score and GCS on admission were 17 and 15, respectively. Overall ICU mortality was 27 %. There were no differences in the occurrence of NWS between antibiotics (39% for MEM, 32% for TZP and 35% for CEF). The occurrence of NWS increased with increasing C min/MIC ranges (P = 0.008); this correlation was found for TZP (P = 0.05) and MEM (P = 0.01), but not for CEF. C min/MIC was an independent predictive factor for NWS (OR 1.12 [1.04-1.20]).
Conclusion:
We found a correlation between high β-lactam trough concentrations and increased occurrence of neurological deterioration in septic ICU patients. Although our data cannot determine causality, monitoring of β-lactam levels should be considered when deterioration of neurological status occurs during critical illness.
Insights
High beta-lactam antibiotic concentrations in septic ICU patients correlate with neurological deterioration. Monitoring drug levels may help identify causes of worsening neurological status during critical illness.
Area of Science:
- Pharmacology
- Critical Care Medicine
- Neuroscience
Background:
- Beta-lactam antibiotics are generally safe but can cause neurotoxicity.
- Septic ICU patients may experience neurological alterations.
- Assessing the link between beta-lactam levels and neurotoxicity is crucial.
Purpose of the Study:
- To evaluate the association between beta-lactam concentrations and neurological changes in septic ICU patients.
- To determine if high drug trough concentrations predict neurological worsening.
Main Methods:
- Retrospective study of ICU patients treated with meropenem, piperacillin-tazobactam, or ceftazidime/cefepime.
- Measured beta-lactam trough concentrations (C min) and normalized to MIC (C min/MIC).
- Assessed neurological status using the change in neurological SOFA score (ΔnSOFA).
Main Results:
- No difference in neurological worsening (NWS) across antibiotic groups.
- NWS occurrence increased with higher C min/MIC ranges (P=0.008).
- C min/MIC was an independent predictor of NWS (OR 1.12).
Conclusions:
- High beta-lactam trough concentrations correlate with neurological deterioration in septic ICU patients.
- Causality cannot be determined, but monitoring is recommended.
- Consider monitoring beta-lactam levels in critically ill patients with neurological decline.
Related Concept Videos
Bacterial Meningitis I: Introduction
Bacterial Meningitis II: Pathophysiology
Brain Abscess l: Introduction
Acute Pyelonephritis II: Diagnostic Studies and Management
Viral Meningitis
Cerebral Edema ll: Pathophysiology

